Cohen Jordana B, Bloom Roy D, Reese Peter P, Porrett Paige M, Forde Kimberly A, Sawinski Deirdre L
Renal, Electrolyte and Hypertension Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kidney Int. 2015 Oct 21. doi: 10.1038/ki.2015.325.
Use of deceased diabetic donor kidneys has increased over recent decades. However, scarce patient and allograft survival data are available taking into account recipient diabetes status. Here we performed a retrospective cohort study using data from the United Network of Organ Sharing in patients transplanted from 1994 to 2014. Multivariable Cox regression assessed recipient outcomes of 9074 diabetic vs. 152,555 non-diabetic donor kidneys. Recipients of diabetic donor kidneys had elevated rates of all-cause allograft failure (hazard ratio 1.21, 95% confidence interval 1.16-1.26) and death (1.19, 1.13-1.24) compared to recipients of kidneys from non-diabetic donors. Younger recipients of diabetic donor kidneys had worse allograft survival than older recipients of non-diabetic donor kidneys. There was significant interaction between donor and recipient diabetes status. To minimize the effect of unmeasured confounders, we used paired analyses of recipients of mate-kidneys from the same donor, with one diabetic recipient and the other non-diabetic. Among discordant recipient pairs of diabetic donor kidneys, diabetic recipients had significantly higher risk of allograft failure (1.27, 1.05-1.53) and death (1.53, 1.22-1.93) than non-diabetic recipients. After stratifying by Kidney Donor Profile Index risk category, diabetic recipients of diabetic donor kidneys continued to have worse allograft survival compared to all other patients. Thus, risks are associated with the use of diabetic donor kidneys. Understanding these risks will enable clinicians to better educate potential recipients.Kidney International advance online publication, 21 October 2015; doi:10.1038/ki.2015.325.
在最近几十年中,已故糖尿病供体肾脏的使用有所增加。然而,考虑到受者的糖尿病状态,患者和移植肾存活数据稀缺。在此,我们进行了一项回顾性队列研究,使用了器官共享联合网络1994年至2014年期间患者的数据。多变量Cox回归评估了9074例接受糖尿病供体肾脏移植患者与152,555例接受非糖尿病供体肾脏移植患者的受者结局。与接受非糖尿病供体肾脏移植的受者相比,接受糖尿病供体肾脏移植的受者全因移植肾失功(风险比1.21,95%置信区间1.16 - 1.26)和死亡(1.19,1.13 - 1.24)的发生率更高。接受糖尿病供体肾脏移植的年轻受者的移植肾存活率低于接受非糖尿病供体肾脏移植的老年受者。供体和受者的糖尿病状态之间存在显著交互作用。为了尽量减少未测量混杂因素的影响,我们对来自同一供体的配偶肾受者进行了配对分析,其中一名受者患有糖尿病,另一名受者未患糖尿病。在接受糖尿病供体肾脏移植的不一致受者对中,糖尿病受者发生移植肾失功(1.27,1.05 - 1.53)和死亡(1.53,1.22 - 1.93)的风险显著高于非糖尿病受者。按肾脏供体特征指数风险类别分层后,接受糖尿病供体肾脏移植的糖尿病受者的移植肾存活率仍低于所有其他患者。因此,使用糖尿病供体肾脏存在风险。了解这些风险将使临床医生能够更好地对潜在受者进行教育。《国际肾脏》在线优先发表,2015年10月21日;doi:10.1038/ki.2015.325